Back, Muscle and Joint Relief
- Product NDC
- 57955-0261
- 11-digit product format
- 579550261
- Labeler code
- 57955
- Product ID
- 57955-0261_9bb49cad-be85-48a5-b164-48b71cda0316
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Aesculus hipp, Arnica, Bellis, Bryonia, Calc carb, Calc fluor, Cimicifuga, Cobaltum met, Gnaphalium poly, Hypericum, Kali carb, Kali phos, Mag phos, Oxalicum ac, Phos, Rhus tox, Ruta, Zinc met
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- King Bio Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2022-02-23
- Marketing end
- 0000-00-00
- Substance
- ARNICA MONTANA WHOLE; BELLIS PERENNIS WHOLE; BLACK COHOSH; BRYONIA ALBA ROOT; CALCIUM FLUORIDE; COBALT; DIBASIC POTASSIUM PHOSPHATE; HORSE CHESTNUT; HYPERICUM PERFORATUM WHOLE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; OXALIC ACID DIHYDRATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; POTASSIUM CARBONATE; PSEUDOGNAPHALIUM OBTUSIFOLIUM WHOLE; RUTA GRAVEOLENS FLOWERING TOP; TOXICODENDRON PUBESCENS LEAF; ZINC
- Active strength
- 10 [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL
- Pharmacologic classes
- Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Standardized Chemical Allergen [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 57955-0261 | D | Discontinued by firm | 2026-10-05 | ||
| excluded package | package | 57955-0261 | 57955-0261-2 | D | Discontinued by firm | 2026-10-05 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 57955-0261-2 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 57955-0261-2 | f5e01cc5f278… | a2eaf40c39c3… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 57955-0261-2 | 57955026102 | 59 mL in 1 BOTTLE, SPRAY (57955-0261-2) | 59 ml | 2022-02-23 | 0000-00-00 | No | No | Current |